Cite
HARVARD Citation
Tausche, A. et al. (n.d.). SAT0307 Lesinurad Monotherapy in Gout Patients Intolerant to Xanthine Oxidase Inhibitors (Light): A Randomized, Double-Blind, Placebo-Controlled, 6-Month Phase III Clinical Trial. Annals of the rheumatic diseases. p. 769. [Online].